Nuestros recursos

A multinational food company needed to assess the safety and efficacy of rice vinegar as a treatment for pre-hypertensive adults, and those at high risk of Cardiovascular disease.

It is notoriously difficult to conduct studies with cohorts of young children and their caregivers due to participant burden and subjectivity in patient-reported outcomes. This fully virtual study, the first of its kind targeting infants and caregivers, will leverage digital instruments and AI to capture and quantify infant cries as a key outcome for colic symptoms and quality-of-life endpoints.

Virtual clinical trials aren’t just a buzzword—these research models are here to stay. In fact, the global market for virtual clinical trials is expected to reach $12.9 billion by 2030, according to Grand View Research.

This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.

A multi-national European pharmaceutical and consumer health company required clinical data to validate the safety and performance of five of its nasal spray and allergy products post CE-mark, in accordance with MDR 2017/745 Annex XIV Part B.

Capturing and assessing patient-reported outcomes is key to driving patient centricity in healthcare research and delivery. However, the life sciences industry has frequently struggled to gather adequate, high-quality participant data in clinical trials, resulting in costly delays for study teams.

A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.

Studying a medical device for the treatment of overactive bladder. ObvioHealth is conducting an innovative study seeking FDA approval of a wearable neuromodulation device for the treatment of overactive bladder (OAB).